Oetgen Stephen Duane bought ARXS
April 17, 2026 · Form 4 insider transaction
Oetgen Stephen Duane bought 5,357 shares of Arxis, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,357
Price
$0.00
Total value
N/A
InsiderOetgen Stephen Duane
RoleDirector
CompanyArxis, Inc. (ARXS)
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateApril 17, 2026
Filing dateApril 20, 2026
Shares owned after5,357
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units with respect to Class A Common Stock which will vest on the first anniversary of the grant date.